Pembrolizumab,Pemetrexed,Cisplatin
merck
['pembro']
5. grade 3 or higher pembro related adverse events occurred in 19% of patients. 16% of patients discontinued pembro per protocol for related aes. #asco23 #patientsafety
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer